quinazolines has been researched along with mci 176 in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (75.00) | 18.7374 |
| 1990's | 2 (25.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abe, Y; Abiko, Y; Ichihara, K | 1 |
| Hosono, M; Taira, N | 1 |
| Iijima, T; Taira, N; Takahashi, K | 1 |
| Imai, S; Ishibashi, T; Nakazawa, M | 1 |
| Abiko, Y; Hara, Y; Ichihara, K | 1 |
| Horii, D; Ishibashi, A | 2 |
| Schleifer, KJ; Tot, E | 1 |
8 other study(ies) available for quinazolines and mci 176
| Article | Year |
|---|---|
Effects of MCI-176, a new quinazolinone calcium antagonist, on myocardial energy and carbohydrate metabolism in ischemic dog hearts.
Topics: Adenine Nucleotides; Adenosine Triphosphate; Animals; Calcium Channel Blockers; Carbohydrate Metabolism; Coronary Disease; Dogs; Energy Metabolism; Female; Heart; Hemodynamics; Male; Myocardium; Phosphocreatine; Phosphofructokinase-1; Quinazolines; Quinazolinones | 1991 |
Coronary vasodilator versus cardiac effects of MCI-176, a novel quinazolinone calcium antagonist, in the dog heart.
Topics: Animals; Blood Flow Velocity; Calcium; Coronary Vessels; Dogs; Dose-Response Relationship, Drug; Female; Heart Conduction System; In Vitro Techniques; Male; Muscle Contraction; Papillary Muscles; Quinazolines; Quinazolinones; Sinoatrial Node; Vasodilation | 1987 |
Voltage- and use-dependent block of the inward calcium current by MCI-176, a new non-dihydropyridine calcium antagonist, in canine ventricular muscles and single ventricular cells of the guinea-pig.
Topics: Action Potentials; Animals; Calcium Channel Blockers; Dogs; Female; Guinea Pigs; Heart; In Vitro Techniques; Ion Channels; Male; Membrane Potentials; Myocardium; Quinazolines; Quinazolinones | 1988 |
Effect of MCI-176, a new calcium channel blocker, on large and small coronary arteries in dogs.
Topics: Adenosine; Animals; Calcium Channel Blockers; Coronary Circulation; Coronary Vessels; Dogs; Dose-Response Relationship, Drug; Male; Quinazolines; Quinazolinones; Vascular Resistance; Vasodilator Agents | 1989 |
MCl-176, a novel calcium channel blocker, attenuates the ischemic myocardial acidosis induced by coronary artery occlusion in dogs.
Topics: Acidosis; Animals; Arterial Occlusive Diseases; Calcium Channel Blockers; Coronary Vessels; Dogs; Female; Heart; Hydrogen-Ion Concentration; Male; Myocardial Infarction; Propranolol; Quinazolines; Quinazolinones | 1988 |
Effect of MCI-176, a new calcium antagonist, on the calcium induced contraction of isolated porcine coronary arteries.
Topics: Animals; Calcium Channel Blockers; Calcium Chloride; Coronary Vessels; Diltiazem; In Vitro Techniques; Muscle Contraction; Muscle, Smooth, Vascular; Nifedipine; Quinazolines; Quinazolinones; Swine | 1987 |
Coronary dilator effect of MCI-176, a new calcium channel blocker, in dogs.
Topics: Animals; Aorta; Blood Flow Velocity; Blood Pressure; Coronary Circulation; Diltiazem; Dogs; Heart Rate; Quinazolines; Quinazolinones | 1986 |
Molecular modeling study of diltiazem mimics at L-type calcium channels.
Topics: Animals; Aorta; Binding Sites; Binding, Competitive; Calcium Channel Blockers; Calcium Channels, L-Type; Cerebral Cortex; Diltiazem; Guinea Pigs; In Vitro Techniques; Ligands; Models, Molecular; Molecular Conformation; Muscle, Skeletal; Muscle, Smooth, Vascular; Quinazolines; Quinazolinones; Rabbits; Structure-Activity Relationship | 1999 |